Skip to main content

Vanda Pharmaceuticals Inc.

VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001347178

No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Vanda Pharmaceuticals Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
178
−11 vs. Q4 2022
Shares held
58.2M
+2.79M (+5.0%) vs. Q4 2022
Total value
$395.9M
−$13.9M (−3.4%) vs. Q4 2022
New holders
20
67 more added
Sold out
31
61 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VNDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 178 institutions
Q1 2021: 189 institutionsQ2 2021: 181 institutionsQ3 2021: 182 institutionsQ4 2021: 198 institutionsQ1 2022: 188 institutionsQ2 2022: 174 institutionsQ3 2022: 178 institutionsQ4 2022: 190 institutionsQ1 2023: 178 institutionsQ2 2023: 188 institutionsQ3 2023: 180 institutionsQ4 2023: 157 institutionsQ1 2024: 144 institutionsQ2 2024: 148 institutionsQ3 2024: 152 institutionsQ4 2024: 146 institutionsQ1 2025: 146 institutionsQ2 2025: 140 institutionsQ3 2025: 150 institutionsQ4 2025: 153 institutionsQ1 2026: 171 institutionsQ2 2026: 172 institutions
Value heldQ1 2023: $395.9M
Q1 2021: $820.0MQ2 2021: $1.18BQ3 2021: $946.9MQ4 2021: $851.4MQ1 2022: $636.7MQ2 2022: $610.6MQ3 2022: $544.1MQ4 2022: $410.0MQ1 2023: $395.9MQ2 2023: $370.7MQ3 2023: $227.2MQ4 2023: $213.8MQ1 2024: $198.0MQ2 2024: $246.0MQ3 2024: $206.3MQ4 2024: $206.7MQ1 2025: $202.1MQ2 2025: $212.4MQ3 2025: $224.0MQ4 2025: $369.4MQ1 2026: $319.4MQ2 2026: $304.1M
Institutions holding VNDA and their total value by quarter
QuarterHoldersValue
Q2 2026172$304.1M
Q1 2026171$319.4M
Q4 2025153$369.4M
Q3 2025150$224.0M
Q2 2025140$212.4M
Q1 2025146$202.1M
Q4 2024146$206.7M
Q3 2024152$206.3M
Q2 2024148$246.0M
Q1 2024144$198.0M
Q4 2023157$213.8M
Q3 2023180$227.2M
Q2 2023188$370.7M
Q1 2023178$395.9M
Q4 2022190$410.0M
Q3 2022178$544.1M
Q2 2022174$610.6M
Q1 2022188$636.7M
Q4 2021198$851.4M
Q3 2021182$946.9M
Q2 2021181$1.18B
Q1 2021189$820.0M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Vanda Pharmaceuticals Inc.; share changes are against Q4 2022.

Institutions holding VNDA in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Sutton Wealth Advisors Inc.0$00.00%−1,515−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−660−100.0%Sold out
Heritage Wealth Advisors0$00.00%−300−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−92−100.0%Sold out
Prestige Wealth Management Group LLC0$00.00%−53−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−50−100.0%Sold out
Money Concepts Capital Corp0$00.00%−7−100.0%Sold out
Private Trust Co NA0$00.00%−20−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−40−100.0%Sold out
Comerica Bank––––Not filed